
Christ Follower. Bible Reader. Pill Pusher. Professor. Hog Fan. Husband to @amyleewit.Proud Dad to Mady Belle.
Conway, Arkansas
Joined December 2008
- Tweets1.9K
- Following2.5K
- Followers506
- Likes3.7K
There is just zero hope on offense for Arkansas. The question is how long will 3rd and long be #wps
64
Wayne Landers retweeted
Watch this installment of Expert Answers in HER2+ Gastroesophageal Cancer to hear Dr. Yelena Janjigian’s perspective on the evolving treatment landscape.
Learn more: bit.ly/4xnohCI
#GastroesophagealCancer #HER2 #Biomarkers #CancerResearch
Wayne Landers retweeted
Severe Thunderstorm Warning is in effect until Aug 22 8:00PM for Pulaski, Faulkner, Perry, Saline. Stay with the Arkansas Storm Team for the newest information. #ARWX #ARStormTeam
Wayne Landers retweeted
Jubilee. A time for rest, return, and redemption. Fulfilled in Jesus. Happy 50th, Little Rock Christian!
#warriorville #lrca #littlerockchristianacademy #50years #jubilee
Wayne Landers retweeted
#News for #Investors and #Media: BeOne Medicines announced today that the European Commission has approved our immunotherapy in combination with chemotherapy as a first-line treatment for adult patients with recurrent or metastatic nasopharyngeal carcinoma (NPC).
NPC is a rare cancer in which malignant cells form in the nasopharynx, the upper part of the throat located behind the nose. Despite advances in cancer care, major unmet needs remain due to late diagnosis, limited treatment options for recurrent/metastatic cases, and regional disparities in access to therapies. We're committed to addressing these gaps—supporting research, access, and innovation to bring hope to patients and families affected by NPC.
ir.beonemedicines.com/news/e…
#BeOneMedicines #NasopharyngealCancer
#Oncology #LungCancer
Wayne Landers retweeted
#Cancer is smart. We must be smarter. Learn how we’re prioritizing quality, speed and efficiency in our R&D efforts to meet the urgent needs of patients worldwide: ft.com/partnercontent/beone-…
#PatientsFirst #CancerHasNoBorders #Oncology
Wayne Landers retweeted
At BeOne Medicines, we’re proud to be a team of individuals – diverse, unique, and united by a shared mission: to change the outlook of cancer. BeOne reflects not just a brand, but the passion and purpose that unify and define us. Every breakthrough, every bold step, is powered by our people.
If you’re onsite at #ASCO25, stop by Booth 30071 to meet the people behind the mission and discover what it truly means to #BeOneAgainstCancer.
#TeamBeOne #BeOneAtASCO
Wayne Landers retweeted
#News for #Investors and #Media: At #ASCO25, we’re unveiling new data from Arm C and D of our Phase 3 SEQUOIA study evaluating our BTK inhibitor in patients with treatment-naïve chronic lymphocytic leukemia (#CLL). These findings reinforce the potential of our BTK inhibitor as a frontline option in CLL/SLL.
To learn more, read our latest press release: ir.beonemedicines.com/news/b…
#CancerResearch
Wayne Landers retweeted
We’re proud to announce our new name—BeOne Medicines—and our redomiciliation to Switzerland are now officially in effect. This marks a major milestone in our evolution as a company.
BeOne is more than just a name change. It reflects who we are today as a leading global oncology company—and our bold ambition to redefine the future of cancer care. With a powerful oncology portfolio, a pioneering approach to clinical development, and expanded global manufacturing and commercial capabilities, we’re well-positioned to deliver transformative treatments to patients worldwide.
As one, we’re uniting patients, families, scientists, physicians, governments, and other oncology public health stakeholders around the world in our shared mission against cancer.
Read more in our press release: ir.beonemedicines.com/news/b…
#BeOneAgainstCancer #CancerCare #Oncology
Wayne Landers retweeted
#News for #Investors and #Media: The European Commission has granted marketing authorization for our immunotherapy in combination with certain chemotherapies as a first-line treatment for extensive-stage small cell lung cancer (#SCLC).
With approximately 70% of SCLC patients diagnosed with extensive-stage disease, treatment options have long been limited. The European Commission's approval of this treatment for eligible patients facing one of the most challenging forms of lung cancer reflects our dedication to advancing the science in areas of high unmet need.
#Oncology #LungCancer
Wayne Landers retweeted
The @US_FDA has approved new dosing options for our PD-1 inhibitor in both first- and second-line esophageal squamous cell carcinoma (#ESCC) and first-line gastric cancer, providing more flexibility for pairing our immunotherapy with the most common chemotherapy regimens.
This approval reinforces our dedication to patients in the U.S. living with upper GI cancers—helping to expand access to personalized treatment approaches and supporting providers in delivering care that fits the unique needs of each patient.
Wayne Landers retweeted
Excited to welcome Melika Davis, SVP & Global Head of Clinical Operations, to the podcast! She’s giving us an inside look at how we manage clinical trials worldwide — from strategy to execution. Don’t miss this behind-the-scenes conversation! Tune in now:
YouTube: ow.ly/CLj950Vw24s
Apple: ow.ly/u3Nq50Vw24r
#ClinicalTrials #Podcast #HealthcareInnovation
Wayne Landers retweeted
Our investigational BTK-targeted CDAC, BGB-16673, attacks a well-validated target with an entirely new approach. This is just one of our pipeline programs with the potential to transform treatment paradigms. Visit ow.ly/rpeS50VrLiG to learn more about our degrader platform.
Wayne Landers retweeted
#News for #Investors and #Media: Today we announced the U.S. FDA has approved our PD-1 inhibitor, in combination with chemotherapy, for the first-line treatment of unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma in adults whose tumors express PD-L1 (≥1). Gastric cancer is the world’s 5th most common cancer, and in the U.S. approximately 27,000 patients are diagnosed each year. This approval marks a significant step forward in our mission to deliver transformative therapies to patients with cancer.
#stomachcancer ow.ly/411350UxfEq
Wayne Landers retweeted
Arkansas administration thought it was doing itself a favor bringing back Sam Pittman for another season.
Pretty sure all it did was set them back five in the process 🤦♂️🤦♂️
Arkansas RB Rashod Dubinion has entered the transfer portal, @mzenitz and I have learned for @247Sports.
He ran for 335 yards and 2 TDs this year on 6 ypc. Also has 42 catches in his career.
247sports.com/player/rashod-…
Wayne Landers retweeted
In 1986, The American Medical Association published an article titled "The Physical Death of Jesus Christ". It details the entire process of Jesus' trial to His death on the cross.
In Luke 22, before Jesus is arrested, it is written that He was in great distress & sweating blood. Although rare, it is recognized as Hematidrosis, caused by high amounts of stress.
At the time, the crucifixion was considered the worst death for the worst of criminals. But this is not all Jesus faced. He endured whipping so severe that it tore the flesh from His body. He was beaten so horribly that His face was torn & His beard ripped.
A crown of thorns, 2-3 inches long cut deeply into His scalp. The leather whip used to flog Him had tiny iron balls & sharp bones. The balls caused internal injuries while the sharp bones ripped open His flesh. His skeletal muscles, veins, & bowels are exposed, causing major blood loss. Most men do not survive this kind of torture. After Jesus was severely flogged, He was forced to carry His cross while people mocked & spat on Him.
Crucifixion was a process meant to instill excruciating pain, creating a slow & agonizing death. Nails as long as 8 inches were driven into Jesus' wrists & feet. The Roman soldiers knew the tendon in the wrists would tear & break, forcing Jesus to use His back muscles to support Himself to breathe. Imagine the struggle, the pain, the courage...Jesus endured this reality for 3 hours!
The Gospel of John writes that after Jesus' death, a Roman soldier pierced His side with a spear & blood & water came out. Scientists explain that from hypovolemic shock, the rapid heart rate causes fluid to gather in the sack around the lungs & heart. The gathering of fluid in the membrane around the heart is called Pericardial effusion & the lungs, Pleural effusion.
To the world, Christianity is as foolish as it can get. They believe it's for the weak. But when you are confronted by the reality of the cross, it's clearly not a pretty sight. It is brutal & horrific.
This is the weight Jesus carried. The weight of the sins of the world, all so that we can live. God's wrath is fully satisfied in Jesus. This is what it took. Repent & believe! Jesus is “God among us” in the flesh. Jesus is our Savior. Jesus loves you so much, He went through this spiritual and physical punishment for your sins and mine.
Jesus is the LORD, Almighty God, Everlasting Father.
Thank You, Jesus.















